Loading stock analysis…
Evidence Synthesis
Last synthesized: 21 Oct 2026, 03:35
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence velocity
Rate-of-change signals for this ticker unlock with Pro — or view flagship demos TCS / RELIANCE.
Evidence Synthesis
Vivimed Labs (VIVIMEDLAB) closed at 6.45 INR on October 19, 2026, with a daily volume of 4,193 shares.
The company's revenue growth has declined by 40.5% year-over-year, while its gross margin has accelerated to 3.36%, up from in the previous quarter. Marginal operating leverage has also decreased to -822.89%, down from -231.26%. The close price has declined by 0.013 INR, from 6.58 INR to .
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 3.36 % | -822.89 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -822.89 % | -231.26 | ▼ |
| REVENUE_GROWTH_YOY | -40.5 % | — | - |
| EPS_ACTUAL | 2.86 INR | — | - |
| EPS_SURPRISE_PERCENT | -0.714 % | — | - |
| PRICE_CHANGE_PERCENT | -1.976 % | — | - |
| DAILY_VOLUME | 4,193 shares | 80,875 | ▼ |
| CLOSE_PRICE | 6.45 INR | 6.58 | ▼ |
Cite this
Source: Samhati evidence synthesis for VIVIMEDLAB (2026-10-21). Observation: Vivimed Labs (VIVIMEDLAB) closed at 6.45 INR on October 19, 2026, with a daily volume of 4,193 shares. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/vivimedlab
Filing step-changes